CompanyDrug

Allist Pharmaceuticals Secures NMPA Approval for Phase I Study of AST2169 Liposome in KRAS G12D Tumors

CompanyDeals

BioGeometry and Sanyou Biopharmaceuticals Forge AI Partnership for Antibody Drug Discovery

CompanyDrug

Sichuan Biokin Gains NMPA Approval for Phase I Study of BL-M05D1 in Advanced Solid Tumors

CompanyDrug

Genor Biopharma Secures NMPA Review for Lerociclib in Advanced Breast Cancer Indication

CompanyDeals

Fosun Pharma Launches RMB 5 Billion Fund to Boost Biopharmaceutical Investments in Shenzhen

Policy / Regulatory

Shanghai Unveils 17 Measures to Enhance Medical Administration Business Environment

CompanyDrug

Pfizer’s Adcetris Combo Shows Improved Survival in Relapsed/Refractory DLBCL Late-Stage Trial

CompanyDeals

MSD Strikes Deal with Pearl Bio to Tap into Synthetic Biology for Oncology Targets

CompanyDeals

MSD Partners with IDEAYA Biosciences to Develop Combination Therapy for Endometrial Cancer

Company

Innovent Biologics Allegedly Closes US Research Facility, Shifts Focus to China

CompanyDeals

VectorBuilder Partners with Minaris Regenerative Medicine to Enhance Gene Therapy Solutions

CompanyDrug

Bio-Thera Solutions Gets Green Light for Phase Ib/II Study of ADC BAT8008 in Advanced Solid Tumors